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The development of in vitro three-dimensional cell culture matrices offers physiologically
relevant alternatives to traditional culture on plastic surfaces. However methods to analyze
cell subpopulations therein are poor. Here we present a simple and inexpensive method
to analyze cell subpopulations in mixed-cell colonies using standard immunohistochem-
ical (IHC) techniques. Brieﬂy, Matrigel™ blocks are sandwiched between two layers of
HistoGel™, hardened by rapid cooling then processed for routine ﬁxation, parafﬁn embed-
ding, and IHC. We demonstrate the assay using mono- and co-cultured normal human
breast, human breast cancer, and transformed mouse stromal cells along with hormone
treated breast cancer cells. Judicious selection of speciﬁc antibodies allows different cell
types within heterotypic colonies to be identiﬁed. A brief pulse of bromodeoxyuridine in
living colonies allows proliferation of cell subpopulations to be quantiﬁed.This simple assay
is useful for multiple cell types, species, and conditions.
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INTRODUCTION
For decades, the ex vivo culture of cell lines has been fundamental
to understanding themechanisms involved in cancer development
and progression. In most cases these studies are performed by cul-
turing cells on two-dimensional (2D) plastic surfaces. Under these
conditions non-malignant cells often lose differentiation, and the
state of malignant cells differs from that of their solid tumor
counterparts (Birgersdotter et al., 2007). This is explained at least
in part by the lack of extracellular matrix signals. Indeed, some
morphological and functional properties can be restored by grow-
ing cells in reconstituted basement membranes (Barcellos-Hoff
et al., 1989; Streuli and Bissell, 1990; Schmidhauser et al., 1992).
Since its discovery in 1983, laminin-rich extracellular matrix [also
known as Matrigel, Cultrex, or Engelbreth-Holm Swarm (EHS)
matrix; Kleinman andMartin, 2005] has been used to culture cells
in 3 dimensions (3D) in conditions that allow cells to replicate
some of the features present in tissues and tumors (Debnath and
Brugge, 2005). Malignant cells show characteristic morphologies
when cultured in 3D that are not observed in 2D (Kenny et al.,
2007). Additionally, 3D culture generally preserves the prolifera-
tion rate (dit Faute et al., 2002), gene expression proﬁle (Li et al.,
2006), and drug sensitivity of cells (dit Faute et al., 2002; Weaver
et al., 2002). Recent studies demonstrate that the stromal layer sur-
rounding the epithelium plays a pivotal role in a wide variety of
biological processes including malignancies (Bissell and Radisky,
2001;Wiseman andWerb, 2002). Therefore the study of cell inter-
actions in heterotypic cultures, for example mixed epithelial and
stromal cultures, has become particularly interesting (Yamada and
Cukierman, 2007;Weigelt and Bissell, 2008). Such studies are pref-
erentially carried out in a 3D environment because of the intrinsic
limitations of mixed-cell 2D culture. Indeed, the study of cells in
3D has become a valid alternative to the use of animal models
(Yamada and Cukierman, 2007) providing a reproducible, con-
trolled microenvironment that resembles the behavior of cancer
cells in solid tumors (Jacks andWeinberg, 2002; Birgersdotter et al.,
2007).
The lack of reliable immunostaining techniques with cell-
speciﬁc antibodies is a major limitation of 3D cultures. Currently
two techniques are available: The ﬁrst involves permeabilizing cells
and visualizing them using expensive equipment such as confocal
microscopy. The second involves whole-culture immunostaining
(Lee et al., 2007) performed in the same chambers in which cells
are grown, which also eventually requires confocal microscopy for
optimal results. In both cases concerns are raised about access of
antibodies into the cells at deeper layers. Here, we present an inex-
pensive and reliable alternative method to immunostain cells and
cell subpopulations grown in 3D culture. This method is applic-
able to any species, cell type, and antigens for which appropriate
antibody combinations are available.
MATERIALS AND METHODS
CELLS LINES
MCF10A cells were obtained from the University of Colorado
Cancer Center Tissue Culture Core. MCF7 cells were from the
Michigan Cancer Foundation. T47D cells were from Iafa Key-
dar (Israel). BT-474 cells were from the American Type Culture
Collection (ATCC,Manassas,VA,USA). All cell lines were authen-
ticated by Single Tandem Repeat analysis at the University of
ColoradoCancer Center SequencingCore. The BJ3Zmousemam-
mary gland malignant stromal cell line was generated in our
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laboratory (Jacobsen et al., 2006). MCF10A cells were routinely
passaged in MEGM medium (Lonza,Walkersville, MD, USA). All
other cell lines were passaged in MEM (Invitrogen, Carlsbad, CA,
USA) containing 5% fetal bovine serum (FBS, HyClone, Logan,
UT, USA).
3D MATRIGEL CULTURE
Cells were seeded into eight-well plastic-chambered glass micro-
scope slides (BDFalcon,CatNo.354118) containing growth-factor
reduced Matrigel™ or phenol red-free growth-factor reduced
Matrigel™ (BDBiosciences,Bedford,MA,USA,CatNos. 354230or
356231 respectively; hereafter calledMatrigel) following a protocol
described by Lee et al. (2007) with minor modiﬁcations. Brieﬂy,
Matrigel (0.5ml aliquots) was thawed on ice for 3–4 h. Individual
wells were coated with 50μl of Matrigel using a p200micropipette
and a 1-ml syringe plunger to spread it evenly. Coated chambers
were incubated at 37˚C while cells were trypsinized and counted.
Cell numbers used were: MCF10A and MCF7 10,000 cells/well or
BT-474 andBJ3Z50,000 cells/well. Cellswere seededon the surface
of Matrigel-coated wells in a total volume of 200μl MEM supple-
mented with 5% twice dextran-coated charcoal (DCC)-stripped
FBS, except forMCF10A forwhichMEGMsupplementedwith 2%
donor horse serum (DHS; GemCell, Gemini, West Sacramento,
CA, USA) was used. Cells were maintained 7 days in an incubator
at 37˚C, 5% CO2 with fresh medium added every 2 days.
PHASE CONTRAST MICROSCOPY
Live cells in eight-well chamberswere photographedonday 6using
a phase contrast ﬁlter in aNikonEclipsemicroscopemodel Ti, cou-
pled to a DS-Qi1Mc camera (Nikon Corp., Japan). Images were
acquired using NIS-Elements Advance Research software version
3.1 (Nikon).
ISOLATION OF 3D CULTURED CELLS
Matrigel/cell blocks were processed on day 7 using the protocol
depicted in Figure 1: a tube of HistoGel™ (Thermo Scientiﬁc
Richard-Allan Scientiﬁc, Kalamazoo, MI, USA; Cat. HG-4000-
012) specimen processing gel was thawed in a water-bath at
65–70˚C for at least 2 h or until the gel was completely lique-
ﬁed, then kept in the water-bath at all times. In Step 1, 5–10min.
before harvesting cells, biopsy cryomolds (Disposable vinyl speci-
men molds 10mm× 10mm× 5mm, Tissue-Tek, Sakura Finetek,
Torrance, CA,USA; Cat No. 4565) were coated with 100–150μl of
warmedHistogel, which was spread evenly to completely cover the
surface of the mold. In Step 2, the surface medium of Matrigel/cell
wells was removed with a pipette tip and aspirator without dis-
turbing the cells. The plastic chamber was removed from the
glass slide using the tool provided by the manufacturer, leav-
ing the Matrigel/cell blocks. These were scraped off the slide
with a clean razor blade (0.009′ single edge, Smith Brand). In
FIGURE 1 | A method to process cells grown in Matrigel for paraffin embedding. Matrigel/cell blocks are encapsulated in a Histogel “sandwich” in biopsy
cryomolds then transferred to blue pathology cassettes for parafﬁn embedding and routine H&E or IHC analyses (details in Materials and Methods)
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Step 3 the Matrigel/cell blocks were transferred onto the His-
togel pre-coated mold using a sterile scalpel (Swann-Morton,
Shefﬁeld England; Cat No.DSS-20). A single Matrigel block (out
of eight) can be transferred, but optimal results were obtained
when four blocks were combined in a single mold. In Step 4
another 100–150μl of warm Histogel was added on top of the
Matrigel to form a“sandwich.”In Step 5 themoldwas immediately
transferred to ice and allowed to solidify for 10min. Matrigel–
Histogel “sandwiches”were then easily transferred by pressing the
back of the molds, popping them out into processing/embedding
blue pathology cassettes (Lab Storage, Cat #6054), which were
closed, ﬁxed ∼16 h in 4% paraformaldehyde, transferred into
70% ethanol, and processed as usual before embedding in
parafﬁn.
FLUORESCENT IMMUNOSTAINING
Parafﬁn blocks containing cells in Matrigel were sectioned
using a standard rotary microtome (Leica Biosystems, Nussloch,
Germany; RM2235). Four or 5μm sections were ﬂoated in a 42–
45˚C water-bath then transferred onto pre-cleaned microscope
glass slides (Mercedes Medical, Sarasota, FL, USA). Dried slides
were baked at 65˚C for 1 h and used for hematoxylin and eosin
(H&E) staining or IHC. For IHC, sections were deparafﬁnized
and antigen retrieval was performed in a pressure cooker (Bio-
care Medical) at 20 psi for 5min in citrate buffer (10mM sodium
citrate, 0.05% Tween-20, pH 6.0). Sections were blocked 30min
with 10%normal goat serum and primary antibodies were applied
against: Cytokeratin 5 (CK5, 1:200, rabbit monoclonal, Epitomics
#2290-1) Pan-cytokeratin (pan-CK, 1:100, mouse monoclonal,
BioLegend #628601); ﬁbroblast activation protein (FAP, 1:100,
rabbit polyclonal, abcam,Cambridge,MA,USA; #ab53066,). Fluo-
rescent secondary antibodies were: Alexa ﬂuor 555 (red) goat anti-
rabbit IgG (1:300) and Alexa ﬂuor 488 (green) goat anti-mouse
IgG (1:400; both Invitrogen). Cell nuclei were counterstained
with 4′-6-Diamidino-2-phenylindole (DAPI). Fluorescent images
were obtained using a Nikon Eclipse E600 ﬂuorescent micro-
scope coupled to a RGB-MS-C micro color camera, and Image
Pro Plus software version 4.5 (MediaCybernetics, Silver Spring,
MD, USA).
DUAL FLUORESCENCE IHC
For MCF10A/BJ3Z co-cultures, a mouse monoclonal antibody
against CK5 (1:100, Leica, NCL-L-CK5) and a rabbit poly-
clonal against alpha-smoothmuscle actin (SMA; 1:400, Epitomics,
Burlingame, CA, USA; #1184-1) were used with the above men-
tioned secondary antibodies. Fluorescent images were obtained as
described.
BrdU INCORPORATION
To assess proliferation, live cells in Matrigel were incubated with
BrdU (0.25mg/ml ﬁnal concentration) 1 hprior to harvesting then
processed as described (Figure 1). Parafﬁn sections were used for
dual ﬂuorescence IHC with two additional steps: after antigen
retrieval, slides were washed in water and, incubated in 2N HCl
for 1 h and in0.1Msodiumborate decahydrate (pH10.5) for 5min
before blocking.MCF10A cells were taggedwith anti-CK14 (1:200,
Thermo Scientiﬁc, Fremont, CA; RB9020-P1), MCF7 and BT-474
cells were tagged with anti-CK18 (1:400, Calbiochem #AP1021),
and proliferating cells were tagged with anti-BrdU (1:50, Becton
Dickinson, San Jose, CA,USA; 347580). For T47D cells in Figure 4
a CK5 rabbit monoclonal was used (Epitomics). Primary antibod-
ies were detected with the above secondary antibodies, nuclei were
counterstained with DAPI, and ﬂuorescent microscope images
were obtained.
HORMONAL TREATMENTS
For hormone treatment experiments T47D cells were plated as
described in phenol red-free Matrigel and treated with ethanol
(1:1,000 v/v) or estrogen (10 nM) plus progesterone (100 nM) for
2weeks, adding fresh hormone or ethanol every 2 or 3 days. At day
14 cells were incubated in BrdU for 1 h, harvested and stained for
CK5 and BrdU as described.
RESULTS
Cells were plated in Matrigel as described by Lee et al. (2007) with
minor modiﬁcations. Matrigel/cell blocks were then processed as
summarized in Figure 1. Brieﬂy, Matrigel/cell blocks are trans-
ferred to HistoGel pre-coated biopsy cryomolds then covered
with a second HistoGel layer to stabilize the Matrigel block,
and hardened. The HistoGel/Matrigel sandwich is ﬁxed, paraf-
ﬁn embedded, and cut into serial sections by standard methods.
These can be stained with (H&E) to assess structure or processed
formulti-color immunohistochemistries (IHC) to identify speciﬁc
cell subpopulations or measure proliferation indices.
Figure 2 (left panels) show characteristic phase contrast 3D
colony morphologies: MCF10A cells form round, apparently hol-
low colonies as described previously (Debnath et al., 2003); MCF7
and BT-474 cells form solid clusters classiﬁed as “masses” (Kenny
et al., 2007); BJ3Z cells form irregular solid masses conﬁrming
their malignant state. Parafﬁn-embedded colonies were serial sec-
tioned and one section was stained by H&E (Figure 2, center).
The method we describe efﬁciently preserves colony architecture,
conﬁrming for example, the hollow nature of the MCF10A spher-
oids. Other sections were used for IHC with primary antibodies
selected for the desired cell type, ﬂuorescent secondary antibod-
ies best suited to the primary, plus counterstaining with DAPI
(Figure 2, right). They were: for MCF10A cells, anti-Cytokeratin 5
(CK5; red); forMCF7 and BT-474 cells, pan-cytokeratin (pan-CK;
green) and for BJ3Z cells, FAP-alpha (red).
The stroma and its cellular components inﬂuence a wide vari-
ety of biological processes (Woodward et al., 1998; Bissell and
Radisky, 2001;Weaver and Gilbert, 2004). Therefore study of het-
erotypic cultures consisting of two or more different cell types in
3D is of particular interest to understand cell-cell interactions in
a controlled environment. For example, Figure 3A shows the 3D
structures that form in a co-culture of human mammary epithe-
lial MCF10A cells with mouse stromal BJ3Z cells, processed by
our method. Cell clusters were stained against human-speciﬁc
CK5, a marker of MCF10A cells (green) and against SMA, a
marker of stromal cells (red). Note that the stromal BJ3Z cells
are at the center, with the MCF10A cells growing as clusters on the
stromal surface.
Another major limitation of current 3D culture methods is the
lack of reliable protocols to measure proliferation of total cells or
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FIGURE 2 | Colonies grown in Matrigel were analyzed by phase
contrast, and by H&E and IHC of paraffin-embedded serial sections.
MCF10A normal human breast, MCF7, and BT-474 human breast cancer, or
BJ3Z activated mouse stromal cells were grown in Matrigel for 7 days. Live
cells were imaged on day 6 by phase contrast (left). Matrigel/cell blocks
were processed on day 7 as described and 5μm parafﬁn sections were
stained with H&E (center). For IHC (right), CK5 detected MCF10A cells
(red); pan-CK detected the human breast cancer cells (green); ﬁbroblast
activation protein (FAP, red) detected the mouse stromal cells. Appropriate
red or green ﬂuorescent secondary antibodies were used and sections
were counterstained with DAPI (blue). Scale: 100μm
cell subpopulations. Most proliferation assays require extraction
of the cells fromMatrigel by enzymatic digestion to obtain single-
cell suspensions, which are then counted with a hemacytometer
(Shekhar et al., 2001) or by ﬂow cytometry (Seidl et al., 2002).
Not only could these assays alter cell behavior during processing;
they also preclude independent analysis of cell subpopulations.
Here we used BrdU incorporation to assess the proliferation rates
of cell subpopulations in mixed 3D cell cultures by incorporating
tandem cell type-speciﬁcmarkers into the assay. Normal or malig-
nant human breast cells were mono-cultured (Figure 3B, left) or
co-cultured with BJ3Z mouse stromal cells (Figure 3B, right) in
Matrigel. Prior to harvesting, 3D cultures were incubated 1 h with
BrdU, which is incorporated into DNA at S-phase and detected
immunologically. Figure 3B (top panels) shows MCF10A normal
human breast cells in mono-culture (left) or in co-culture with
BJ3Z mouse stromal cells (right). MCF10A cells are identiﬁed
by CK14 expression (red) and BrdU is identiﬁed by green ﬂuo-
rescence. In mono-culture, few if any MCF10A cells incorporate
BrdU; co-culture with BJ3Z increasesMCF10A proliferation. Note
that the central DAPI-positive (blue) BJ3Z cells are CK14-negative
and non-proliferative.
Figure 3B (middle) shows MCF7 human breast cancer cells,
and Figure 3B (bottom) shows BT-474 human breast cancer
A
B
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FIGURE 3 |Three-dimensional cell subpopulations and proliferation
rates. (A) MCF10A/BJ3Z co-cultures were stained against SMA (red) to tag
the mouse stromal cells and anti-human CK5 (green) to tag the MCF10A
cells. (B) Proliferation as measured by BrdU incorporation in different cell
subpopulations. Human MCF10A, MCF7, or BT-474 cells were grown in 3D
mono-culture (left) or in co-culture with BJ3Z mouse stromal cells (right).
Anti-CK14 (red) was used for MCF10A cells; anti-CK18 (red) was used for
MCF7 and BT-474 cells. All sections were dual stained for BrdU (green) and
counterstained with DAPI (blue). Note enhanced proliferation of BJ3Z
co-cultured breast cells and lack of stromal cell proliferation.When cells of
different species are co-cultured, judicious choice of primary antibody pairs
and ﬂuorescent second antibodies is required. Scale: 100μm
cells inmono-culture or co-culture with BJ3Zmouse stromal cells.
CK18 expression (red) was used to distinguish the breast epithelial
cells from the stromal cells that they surround. Proliferation of the
breast cancer cells (left) is increased by co-culture with stromal
cells (right). The methods shown here can be used for any mono
or heterotypic 3D cultured cells to assess their proliferation rate
or combined with any other marker of interest provided speciﬁc
antibodies are available.
Finally, previous studies have shown that ovarian hormones,
namely estrogens (E) and progesterone (P) play a key role in
breast tumor growth anddifferentiation (Clemons andGoss, 2001;
Hankinson et al., 2004; Harrell et al., 2006) and that markers like
CK5 identify cancer cell subpopulations with stem-like properties
(Horwitz et al., 2008). Paradoxically, these cell subsets are charac-
terized by low proliferation rates along with their enhanced ability
to initiate tumors (Horwitz et al., 2008; Kabos et al., 2010). Recent
studies suggest that ovarian hormones promote expansion of a
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FIGURE 4 | Hormone treatment induces basal-like Cytokeratin 5 (CK5)
expression in a subset of luminal breast cancer cells. ER+PR+T47D
cells were incubated with ethanol (Control) or a combination of estrogen
and progesterone (E+P). Cells were also incubated in BrdU (green) to
assess proliferation. Following E+P treatment, a subset of cells expressing
CK5 (red) is expanded, that has little or no proliferative activity. Scale:
100μm.
stem-cell pool in the mammary glands of mice (Asselin-Labat
et al., 2010; Joshi et al., 2010). Figure 4 shows T47D human
breast cancer cells in 3D phenol red-free Matrigel colony cultures
treated with either ethanol (Control, left) or a combination of
E+P (right). Previous studies have shown that T47D cells express
both estrogen (ER) and the progesterone (PR) receptor when cul-
tured under these conditions (not shown).Note that in the absence
of hormones (E or P) cells form relatively small colonies that lack
CK5. Treatment of cells with E+P enlarges the colony clusters and
triggers expression of CK5 (red) in a subset of cells. Pre-incubation
of cells with BrdU allows quantiﬁcation of proliferation in these
cell subsets. Importantly, while proliferating cells (green nuclei)
are present in both the control and E+P treated CK5-negative
subpopulations, the CK5-positive stem-like cells do not take up
BrdU and appear to be relatively quiescent.
DISCUSSION
During the last decade the development of 3D culture models
have offered physiologically relevant alternatives to traditional 2D
culture on plastic surfaces (Jacks and Weinberg, 2002; Kim et al.,
2004; Debnath and Brugge, 2005; Kim, 2005; Weigelt and Bissell,
2008).However, study of cells in 3Dcultures has beenhampered by
lack of simple methods to analyze them. Current techniques are
time-consuming, require expensive equipment such as confocal
microscopy for optimal results, and are poorly adapted to study
cell subpopulations. Here we present a reliable, easy, and inex-
pensive method to transfer 3D cultured cells into parafﬁn blocks.
Embedded cells can be sectioned in amicrotome and used for rou-
tine H&E staining and standard IHC assays that target different
cell types. A previous study used cells grown in 3D to generate
sections for H&E stains (Kunz-Schughart et al., 2001). This study
used cells grown on agarose which lacks the basement membrane
components of Matrigel that inﬂuence cell behavior andmorphol-
ogy (Streuli and Bissell, 1990; Schmidhauser et al., 1992). A second
recent study used human plasma and thrombin to generate a solid
clot when added to Matrigel (Graham et al., 2009), allowing the
transfer of cells for parafﬁn embedding. Results of this technique
are similar to ours by allowing IHC and preserving the 3D mor-
phology of cell colonies. However, processing to obtain plasma
is time-consuming, requires regular access to human blood for
plasma extraction including human research approval, and addi-
tion of plasma and thrombin to cells may affect their physiological
properties.
In vivo, cells are inﬂuenced not only by the extracellular matrix
but also by neighboring cells. Therefore methods to study het-
erotypic 3D cultures are essential (Kim et al., 2004; Weigelt and
Bissell, 2008). A few heterotypic 3D models have been recently
described: Shekhar et al. (2001) reported ductal–alveolarmorpho-
genesis when MCF10A cells were co-cultured with tumor-derived
breast ﬁbroblasts. This effect was enhanced by the presence of
human umbilical cord vascular endothelial cells. In this study, the
investigators transferred the 3D cultured cells into parafﬁn blocks
for H&E and colorimetric IHC analyses, but no technical details
of their methods were provided. To determine cell proliferation,
the cells were counted in a hemacytometer following enzymatic
digestion of the Matrigel. Another report (Ronnov-Jessen et al.,
1995) used cryo-sections, which are subject to freezing artifacts,
changes inmorphology andother limitations, to analyze cells in 3D
collagen gels. Triple immunostaining showed that primary tumor
cells converted normal SMA negative ﬁbroblasts into SMA posi-
tive myoﬁbroblasts. A recent report (Sasser et al., 2007) showed
that proliferation of breast cancer cell lines in 3D was enhanced
by co-culture with human bone marrow stromal cells. While this
method efﬁciently quantiﬁed cell numbers in 3D, it required use
of ﬂuorescently pre-tagged cells.
The method presented here (Figure 1) preserves the 3D archi-
tecture of any cell type in mono- or co-culture with permanent
parafﬁn sections and does not require ﬂuorescent pre-tagged cells.
BrdU incorporation allows quantiﬁcation of proliferation in any
desired cell subpopulation provided cell-speciﬁc antibodies are
available (Figure 3). Of interest is the fact that by employing tra-
ditional IHC techniques the method can be used to optimize IHC
conditions when tumors or other valuable samples are scarce.
The study of heterotypic 3D cultures is critical for understand-
ing cell-cell interactions and the signal transduction pathways
involved in the behavior of normal and cancer cells in an environ-
ment that resembles in vivo tissue or tumor conditions (Debnath
and Brugge, 2005; Yamada and Cukierman, 2007). The putative
role of ovarian hormones in expanding a breast cancer stem-like
cell subpopulation (Figure 4) is a case in point. The development
of simple IHC techniques that can be applied to 3D models offers
excellent alternatives to costly animal models and their intrinsic
variability. 3D models allow high throughput mechanistic stud-
ies of cell behavior, proliferation, apoptosis and migration, and
lend themselves to high throughput drug screening (Friedrich
et al., 2009) of anti-cancer agents while targeting cells in appro-
priate microenvironments (Bissell and Radisky, 2001). The assay
described here adds to the power of 3D models.
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